Cargando…

Fibrinolytic and antithrombotic therapy : theory, practice, and management /

Thrombotic disorders of the circulatory system represent the leading cause of morbidity, mortality, and health care expenditure in the United States. The Second Edition of Fibrinolytic and Antithrombotic Therapy provides a practical, evidence-based approach to the managment of thrombotic disorders f...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Becker, Richard C.
Otros Autores: Spencer, Fredrick A., MD
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Oxford ; New York : Oxford University Press, 2006.
Edición:2nd ed.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a22000004a 4500
001 EBOOKCENTRAL_ocm71794280
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu---unuuu
008 060928s2006 enka ob 001 0 eng d
010 |a  2005012980 
040 |a N$T  |b eng  |e pn  |c N$T  |d YDXCP  |d OCLCG  |d OCLCQ  |d N$T  |d OCLCQ  |d E7B  |d CBT  |d OCLCQ  |d NLGGC  |d OCLCO  |d OCLCQ  |d EBLCP  |d OCLCQ  |d AZK  |d TOA  |d AGLDB  |d MOR  |d OCLCO  |d PIFAG  |d ZCU  |d OCLCO  |d MERUC  |d OCLCO  |d OCLCQ  |d OCLCO  |d WY@  |d OCLCO  |d OCLCA  |d U3W  |d OCLCO  |d OCLCA  |d LUE  |d OCLCO  |d OCLCF  |d OCLCO  |d STF  |d WRM  |d OCLCQ  |d VTS  |d CEF  |d ICG  |d NRAMU  |d VT2  |d AU@  |d OCLCO  |d OCLCQ  |d LHU  |d OCLCO  |d FVL  |d OCLCQ  |d WYU  |d UWO  |d OCLCO  |d OCLCA  |d CANPU  |d OCLCO  |d REC  |d OCLCO  |d DKC  |d OCLCQ  |d CNTRU  |d OCLCO  |d MT4IT  |d UX1  |d OCLCA  |d UKCRE  |d UKAHL  |d OCLCO  |d SGP  |d OCLCO  |d OCLCQ  |d SFB  |d OCLCQ  |d OCLCO  |d OCLCL 
015 |a GBA616392  |2 bnb 
015 |a GBA616392.  |2 bnb 
016 7 |z 101247345  |2 DNLM 
016 7 |z 013385935  |2 Uk 
016 7 |z 013385935.  |2 Uk 
016 7 |z 101247345.  |2 DNLM 
019 |a 647897721  |a 764534359  |a 961485118  |a 962646807  |a 988492310  |a 991913422  |a 992050685  |a 1035697255  |a 1037927771  |a 1038668593  |a 1045522518  |a 1059790148  |a 1064644548  |a 1081256274  |a 1099557953  |a 1153504722 
020 |a 9780199749065  |q (electronic bk.) 
020 |a 019974906X  |q (electronic bk.) 
020 |a 1429402733 
020 |a 9781429402736 
020 |z 9780195155648  |q (alk. paper) 
020 |z 0195155645  |q (alk. paper) 
027 |a MYILIB_CUp 
029 1 |a AU@  |b 000044593692 
029 1 |a AU@  |b 000051581888 
029 1 |a AU@  |b 000062338105 
029 1 |a DEBBG  |b BV043118871 
029 1 |a DEBBG  |b BV044094264 
029 1 |a DEBSZ  |b 422253847 
029 1 |a NZ1  |b 13863936 
029 1 |a YDXCP  |b 2472905 
029 1 |a AU@  |b 000069138377 
029 1 |a AU@  |b 000060545862 
035 |a (OCoLC)71794280  |z (OCoLC)647897721  |z (OCoLC)764534359  |z (OCoLC)961485118  |z (OCoLC)962646807  |z (OCoLC)988492310  |z (OCoLC)991913422  |z (OCoLC)992050685  |z (OCoLC)1035697255  |z (OCoLC)1037927771  |z (OCoLC)1038668593  |z (OCoLC)1045522518  |z (OCoLC)1059790148  |z (OCoLC)1064644548  |z (OCoLC)1081256274  |z (OCoLC)1099557953  |z (OCoLC)1153504722 
050 4 |a RC694.3  |b .B39 2006eb 
055 1 3 |a RC694.3  |b .B39 2006eb 
060 0 0 |a 2006 F-938 
060 1 0 |a QZ 170  |b B396f 2006 
072 7 |a MED  |x 010000  |2 bisacsh 
082 0 4 |a 616.1/3506  |2 22 
049 |a UAMI 
100 1 |a Becker, Richard C. 
245 1 0 |a Fibrinolytic and antithrombotic therapy :  |b theory, practice, and management /  |c Richard C. Becker, Frederick A. Spencer. 
250 |a 2nd ed. 
260 |a Oxford ;  |a New York :  |b Oxford University Press,  |c 2006. 
300 |a 1 online resource (x, 410 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
505 0 |a Historical perspectives in hemostasis, coagulation and fibrinolysis -- Vascular biology, thromboresistance and inflammation -- Atherosclerosis and arterial thrombosis -- Venous thromboembolism -- Cardiac chamber, aortic and valvular thromboembolism -- Fibrinolytic agents -- Aspirin -- Clopidogrel -- Platelet Glycoprotein IIb/IIIa receptor antagonists -- Aggrenox and cilostazol -- Novel platelet antagonists. 
505 0 |a Combination pharmacotherapy -- Facilitated percutaneous coronary intervention -- Thrombin-directed therapy -- Factor Xa inhibitors -- Direct thrombin inhibitors -- Novel anticoagulants -- Acute coronary syndromes -- Peripheral vascular disease and stroke -- Valvular heart disease and atrial fibrillation -- Plaque-stabilizing therapies. 
505 0 |a Venous thromboembolism prophylaxis -- Venous thromboembolism treatment -- Fundamentals and patient evaluation -- Platelet antagonists -- Anticoagulants -- Anticoagulation clinics and self-testing -- Platelet antagonists -- Anticoagulants -- Fibrinolytic agents. 
588 0 |a Print version record. 
520 8 |a Thrombotic disorders of the circulatory system represent the leading cause of morbidity, mortality, and health care expenditure in the United States. The Second Edition of Fibrinolytic and Antithrombotic Therapy provides a practical, evidence-based approach to the managment of thrombotic disorders for all clinicians involved in the care of patients with these disorders. It provides not only vital conceptual information on fibrinolytic and antithrombotic therapy, but also the means to apply it to everyday decision making and patient care. Focusing on management guidelines and critical pathways, the text stresses practicality and usability. It will be a valuable resource for the wide range of clinicians involved in the care of patients with these disorders. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Thrombolytic therapy. 
650 0 |a Fibrinolytic agents. 
650 0 |a Thrombosis  |x Treatment. 
650 1 2 |a Thrombolytic Therapy  |x methods 
650 2 2 |a Blood Coagulation Disorders  |x drug therapy 
650 2 2 |a Blood Coagulation Disorders  |x physiopathology 
650 2 2 |a Cardiovascular Diseases  |x drug therapy 
650 2 2 |a Fibrinolytic Agents  |x therapeutic use 
650 2 |a Thrombolytic Therapy 
650 2 |a Fibrinolytic Agents 
650 6 |a Thrombolyse. 
650 6 |a Fibrinolytiques. 
650 6 |a Thrombose  |x Traitement. 
650 7 |a MEDICAL  |x Cardiology.  |2 bisacsh 
650 7 |a Fibrinolytic agents  |2 fast 
650 7 |a Thrombolytic therapy  |2 fast 
700 1 |a Spencer, Fredrick A.,  |c MD. 
758 |i has work:  |a Fibrinolytic and antithrombotic therapy (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGYFtf9kTy89vhhXrQrbcX  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Becker, Richard C.  |t Fibrinolytic and antithrombotic therapy.  |b 2nd ed.  |d Oxford ; New York : Oxford University Press, 2006  |z 0195155645  |w (DLC) 2005012980  |w (OCoLC)60348893 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3053633  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH38694139 
938 |a EBL - Ebook Library  |b EBLB  |n EBL3053633 
938 |a ebrary  |b EBRY  |n ebr10375127 
938 |a EBSCOhost  |b EBSC  |n 168946 
938 |a YBP Library Services  |b YANK  |n 3248552 
938 |a YBP Library Services  |b YANK  |n 2472905 
994 |a 92  |b IZTAP